Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption

Area of Science:

• Immunology
• Biotechnology
• Cell Biology

Background:

• Cell depletion from human bone marrow is crucial for transplantation.
• Existing methods may impact hematopoietic progenitor recovery.

Purpose of the Study:

• To develop and evaluate a novel avidin-biotin immunoadsorption technique for selective cell depletion from human bone marrow.
• To assess the efficiency of this method in removing target cells while preserving hematopoietic progenitors.

Main Methods:

• Utilized biotinylated antibodies and avidin-Sepharose columns for cell depletion.
• Employed fluorescein-labeled Daudi lymphoblasts as target cells in a human bone marrow model.
• Quantitatively assessed cell removal using an inverted fluorescent microscope.

Main Results:

• Achieved greater than two logs of Daudi cell removal using a biotinylated monoclonal antibody (2H7) and avidin-Sepharose.
• An alternative method using biotinylated goat antimouse immunoglobulin enabled up to three logs of Daudi cell elimination.
• Demonstrated quantitative recovery of hematopoietic progenitors alongside successful target cell depletion.

Conclusions:

• The avidin-biotin immunoadsorption system offers an effective strategy for selective cell depletion from bone marrow.
• The use of biotinylated goat antimouse immunoglobulin simplifies the process by eliminating the need for individual antibody biotinylation.
• This technique shows promise for clinical applications in bone marrow transplantation.